AMRINDER MANGAT: Open Payments
NPI 1285214999 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 17 payments from 8 companies in 2025. Trend: 2023 $557 · 2024 $368 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $89 |
| AstraZeneca Pharmaceuticals LP | 3 | $71 |
| Amgen Inc. | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Boston Scientific Corporation | 1 | $33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $30 |
| Mannkind Corporation | 1 | $24 |
Products named: LEQVIO, REPATHA, JARDIANCE, VERQUVO, WATCHMAN Access System, LifeVest, WAINUA, LOKELMA.
Industry payments across IL — which companies pay providers there.
